Centre to cap trade margins on non-scheduled cancer drugs to 30% of MRP
Average trade mark-up on these drugs now around 170%, reaching 700% in some cases; intervention to cut prices by up to 70% of MRP, resulting in cumulative annual savings of ₹2,500 crore for patients
· 10/8/2026, 4:39:39 PM· 2 min read
Average trade mark-up on these drugs now around 170%, reaching 700% in some cases; intervention to cut prices by up to 70% of MRP, resulting in cumulative annual savings of ₹2,500 crore for patients
Read original story →Related stories
breaking
Mamata Banerjee likely to join CJP protests on October 10
breaking
Students must focus on technological advancements, says Ambedkar University Dean
breaking
ED searches 17 locations in Keralam over alleged co-op. bank fraud
breaking